Teva Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Teva Pharmaceuticals USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013913
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Teva Pharmaceuticals USA Inc (Teva Pharmaceuticals), formerly Lemmon Pharmacal Company, a subsidiary of Teva Pharmaceutical Industries Ltd, is a developer and manufacturer of pharmaceutical ingredients. The company’s products include antiulcer agents and acid suppressants, antiviral capsules, analgesics, anti-glaucoma agents, tamsulosin hydrochloride, losartan potassium, contraceptives, antacid tablets, laxatives, anti-inflammatory drugs, antibacterial injection, corticosteroids, hydrochlorothiazide, dorzolamide hydrochloride ophthalmic solutions and pramipexole dihydrochloride. It also provides generic drugs and over-the-counter healthcare products. The company also commercializes products through wholesalers, retail chains, distributors and government agencies. It operates through its offices in the US and Israel. Teva Pharmaceuticals is headquartered in North Wales, Pennsylvania, the US.

Teva Pharmaceuticals USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Teva Pharmaceuticals USA Inc, Medical Devices Deals, 2011 to YTD 2017 9
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Cephalon To Acquire Assets Related To Larazotide Acetate From Alba Therapeutics 12
Venture Financing 13
SymBio Pharma Secures US$24.5 Million In Series E Financing Round 13
Private Equity 14
Partners In Life Sciences Acquires Manufacturing Facility In Mitry-Mory From Cephalon 14
Partnerships 15
Champions Biotech Enters Into An Agreement With Cephalon 15
Celator Pharma Extends Research Agreement With Cephalon 16
Licensing Agreements 17
Teva Pharma Enters into Licensing Agreement with CSPC Zhongqi Pharma 17
Checkpoint Therapeutics Enters into Licensing Agreement with Cephalon 18
Intellipharmaceutics Enters into Licensing Agreement with Teva Pharma 19
Lundbeck Enters Into Licensing Agreement With Cephalon 20
APP Pharma Enters Into Licensing Agreement With Teva Pharma For Gemcitabine HCI 21
ImmunGene Enters Into Licensing Agreement With Cephalon 22
Asset Transactions 23
Ignyta Acquires Four Oncology R&D Assets from Cephalon 23
ANI Pharma Acquires ANDA from Teva Pharma 25
ANI Pharma Acquires 22 Generic Drug Products from Teva Pharma 26
Amedra Pharmaceuticals Acquires Mebendazole Tablet Product from Teva Pharmaceutical 27
Acquisition 28
Ind-Swift Lab May Sell Stake in Company 28
Teva Completes Acquisition Of Cephalon For US$6,800 Million 29
Cephalon Acquires 91.73% Stake In ChemGenex 31
Cephalon Acquires Gemin X Pharma 33
Cephalon Completes Acquisition Of 20% Stake In Mesoblast 35
Teva Pharmaceuticals USA Inc – Key Competitors 37
Teva Pharmaceuticals USA Inc – Key Employees 38
Teva Pharmaceuticals USA Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Legal and Regulatory 40
Jun 22, 2017: Wockhardt and its Subsidiaries settle with Teva and its Affiliate a commercial litigation in the High Court, London 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Key Facts 2
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Teva Pharmaceuticals USA Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Teva Pharmaceuticals USA Inc, Medical Devices Deals, 2011 to YTD 2017 9
Teva Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cephalon To Acquire Assets Related To Larazotide Acetate From Alba Therapeutics 12
SymBio Pharma Secures US$24.5 Million In Series E Financing Round 13
Partners In Life Sciences Acquires Manufacturing Facility In Mitry-Mory From Cephalon 14
Champions Biotech Enters Into An Agreement With Cephalon 15
Celator Pharma Extends Research Agreement With Cephalon 16
Teva Pharma Enters into Licensing Agreement with CSPC Zhongqi Pharma 17
Checkpoint Therapeutics Enters into Licensing Agreement with Cephalon 18
Intellipharmaceutics Enters into Licensing Agreement with Teva Pharma 19
Lundbeck Enters Into Licensing Agreement With Cephalon 20
APP Pharma Enters Into Licensing Agreement With Teva Pharma For Gemcitabine HCI 21
ImmunGene Enters Into Licensing Agreement With Cephalon 22
Ignyta Acquires Four Oncology R&D Assets from Cephalon 23
ANI Pharma Acquires ANDA from Teva Pharma 25
ANI Pharma Acquires 22 Generic Drug Products from Teva Pharma 26
Amedra Pharmaceuticals Acquires Mebendazole Tablet Product from Teva Pharmaceutical 27
Ind-Swift Lab May Sell Stake in Company 28
Teva Completes Acquisition Of Cephalon For US$6,800 Million 29
Cephalon Acquires 91.73% Stake In ChemGenex 31
Cephalon Acquires Gemin X Pharma 33
Cephalon Completes Acquisition Of 20% Stake In Mesoblast 35
Teva Pharmaceuticals USA Inc, Key Competitors 37
Teva Pharmaceuticals USA Inc, Key Employees 38
Teva Pharmaceuticals USA Inc, Other Locations 39
Teva Pharmaceuticals USA Inc, Subsidiaries 39

★海外企業調査レポート[Teva Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Singapore Power Limited:企業の戦略・SWOT・財務情報
    Singapore Power Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bank Sinopac:企業の戦略・SWOT・財務分析
    Bank Sinopac - Strategy, SWOT and Corporate Finance Report Summary Bank Sinopac - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Anglo Pacific Group plc:企業のM&A・事業提携・投資動向
    Anglo Pacific Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo Pacific Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Fog Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fog Pharmaceuticals Inc (Fog Pharmaceuticals) is a clinical-stage biotechnology company that discovers and develops next-generation peptide inhibitors that target traditionally undruggable intracellular protein-protein interactions. The company develops cell-penetrating miniproteins (CPMPs), …
  • Amedica Corp (AMDA):製品パイプライン分析
    Summary Amedica Corp (Amedica) is a biomaterial company. It develops, manufactures and markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems and others. Amedica also offers n …
  • OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Extraction Oil & Gas Inc (XOG):企業の財務・戦略的SWOT分析
    Extraction Oil & Gas Inc (XOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Gainesville Regional Utilities:企業の戦略的SWOT分析
    Gainesville Regional Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Trent Ltd (TRENT):企業の財務・戦略的SWOT分析
    Trent Ltd (TRENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mediobanca Banca di Credito Finanziario S.p.A.:企業の戦略・SWOT・財務情報
    Mediobanca Banca di Credito Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Banca di Credito Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • GenomicTree Co Ltd (228760):企業の製品パイプライン分析
    Summary GenomicTree Co Ltd (GenomicTree) is a medical device company that develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic product. Its products are used in the detection of colorectal, lung …
  • BNK Petroleum Inc (BKX):石油・ガス:M&Aディール及び事業提携情報
    Summary BNK Petroleum Inc (BNK Petroleum) is an oil and gas company. The company explores, produces and acquires large hydrocarbon reserves. The company’s project includes Tishomingo Field, Gapowo B-1 well and other operations in Spain. Its Tishomingo Field is located in Ardmore Basin in Oklahoma, t …
  • Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Cyxone AB-製薬・医療分野:企業M&A・提携分析
    Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company’s lead product include T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis …
  • Urstadt Biddle Properties Inc:企業の戦略・SWOT・財務分析
    Urstadt Biddle Properties Inc - Strategy, SWOT and Corporate Finance Report Summary Urstadt Biddle Properties Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Komeri Co Ltd:企業の戦略・SWOT・財務情報
    Komeri Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Komeri Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Audentes Therapeutics Inc (BOLD)-製薬・医療分野:企業M&A・提携分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …
  • Tactile Systems Technology Inc (TCMD):製品パイプライン分析
    Summary Tactile Systems Technology Inc (Tactile Medical) is a medical technology company that develops, manufactures and distributes medical devices for the treatment of chronic vascular diseases in a home setting. The company’s products are based on a unique, scalable platform. It offers products f …
  • Valbiotis SAS (ALVAL):製薬・医療:M&Aディール及び事業提携情報
    Summary Valbiotis SAS (Valbiotis) is a biotechnology company that develops novel solutions to help prevent cardiometabolic diseases, besides nutrition products. It develops solutions to prevent type 2 diabetes, non-alcoholic steatohepatitis (NASH), obesity and cardiovascular diseases. The company ha …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆